Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer gets CRL on Epogen biosimilar from FDA
According to Pfizer, the letter is related to points made by the regulator in a February-issued warning letter after a routine inspection of the pharma’s McPherson facility in
According to Pfizer, the letter is related to points made by the regulator in a February-issued warning letter after a routine inspection of the pharma’s McPherson facility in
The topline results from the trial have showed that the drug in combination with standard of care ACZ885 reduces the risk of major adverse cardiovascular events (MACE), a
Shingrix is being developed for the prevention of shingles, better known than herpes zoster, a painful, itchy rash condition caused by reactivation of latent chickenpox virus. The vaccine
Mydayis is a once-daily treatment and prescription medicine, which includes three different types of drug-releasing beads to control ADHD in patients 13 years and older. Shire plans to
Under the deal, Pamplona will purchase all of the outstanding shares of Parexel for $88.10 per share in cash, representing a 27.9% premium to its closing stock price
The action was taken by the biotechnology company after consultation with the Independent Data Monitoring Committee (IDMC) and a review of the unblinded data of the trial dubbed
The approval has been granted for Rixathon to be used in all indications of the reference medicine, MabThera. Novartis has received approval for Rixathon to treat non-Hodgkin's lymphoma
Dysport was approved in July 2015 to treat upper limb spasticity in adults. In July 2016, it was approved for the treatment of pediatric patients with lower limb
The new data also showed that two years of Cosentyx treatment resulted in rapid and sustained pain relief in patients with active PsA. Novartis says that the new
NICE has recommended Kadcyla for routine funding on the NHS, enabling the drug to be available in the normal way.Currently, Kadcyla is being funded through the Cancer Drugs